Priming of alveolar macrophages by leukotriene D4: Potentiation of inflammation

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 4, 2000, Pages 572-577

  Menard, G ^a   Bissonnette, E Y ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033792827     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.4.4152     Document Type: Article

References (35)

1. The airway inflammatory response in allergic asthma and its relationship to clinical disease
2. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide
3. Cytokines in asthma
4. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients
5. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
6. Leukotrienes in asthma: The potential therapeutic role of antileukotriene agents
7. Bay u9773, a novel antagonist of cysteinyl leukotrienes with activity against two receptor subtypes
8. Characterization of the human cysteinyl leukotriene CysLT1 receptor
9. Characterization of specific receptors for leukotriene D4 on human alveolar macrophages
10. Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: Cellular selectivity, reversibility, and early events in T cell activation
11. The role of the alveolar macrophage in asthma
12. 3 receptors. Stimulation of IL-10 production
13. A continuous alveolar macrophage cell line: Comparisons with freshly derived alveolar macrophages
14. Inducible nitric oxide synthase from a rat alveolar macrophage cell llne is inhibited by nitric oxide
15. IFN-γ potentiates the release of TNF-α and MIP-α by alveolar macrophages during allergic reactions
16. Potentiation of TNF-α mediated cytotoxicity of mast cells by their production of nitric oxide
17. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists
18. Montelukast added to inhaled beclomethasone in treatment of asthma
19. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
20. Induced sputum eicosanoid concentrations in asthma
21. Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects
22. Complement receptor enhancement and chemotactis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products
23. 4 receptor antagonist
24. 4 and granulocytic infiltration into asthmatic airways
25. Eotaxin: Cloning of an eosinophil chemoattractant cytokine and increased mNRA expression in allergen-challenge guinea-pig lungs
26. Redundancy or cell type specific regulation? TNF in alveolar macrophages and mast cells
27. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects
28. Cachectin tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses
29. Nitric Oxide. I. Physiological Chemistry of nitric oxide and its metabolites: Implications in inflammation
30. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma
31. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist Montelukast
32. Constitutive nitric oxide production by rat alveolar macrgphages
33. Viruses as precipirants of asthma symptoms: II. Physiology and mechanisms
34. Bacterial infection as an important triggering factor in bronchial asthma
35. Endotoxin-induced lung inflammation is independent of the complement membrane attack complex